MFS
REGN icon

McNamara Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

McNamara Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,925
Closed -$1.36M – 71
2015
Q3 		$1.36M Buy
2,925
+395
+16% +$212K 1.43% 37
2015
Q2 		$1.29M Sell
2,530
-1,920
-43% -$937K 1.22% 42
2015
Q1 		$2.01M Sell
4,450
-2,500
-36% -$1.06M 1.85% 30
2014
Q4 		$2.85M Buy
+6,950
New +$2.73M 2.6% 2

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

McNamara Financial Services's REGN Position: Q4 2015 in Review

McNamara Financial Services sold out of Regeneron Pharmaceuticals (REGN) in Q4 2015, closing a stake of 2,925 shares — an estimated $1.36M sold.

McNamara Financial Services first reported a position in REGN in Q4 2014 and held it in 4 quarters. The position peaked at $2.85M in Q4 2014. 577 funds tracked by Wall St. Rank hold REGN as of Q4 2015.

  • McNamara Financial Services reported no remaining Regeneron Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • McNamara Financial Services sold 2,925 Regeneron Pharmaceuticals shares in Q4 2015, an estimated $1.36M.
  • McNamara Financial Services first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • McNamara Financial Services's Regeneron Pharmaceuticals position peaked at $2.85M in Q4 2014.
  • 577 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2015.

Based on McNamara Financial Services's 13F filing for Q4 2015, filed 27 Jan 2016.